Since this treatment has now been available for over three years, I’m curious whether any documented case reports exist showing patients who achieved meaningful additional growth from continued long-term use. The webinar mentioned more than 800 patients, with a large percentage opting to keep going. If the results reported in the study (roughly 1
Inch in length and 0.6 inches in
Girth after six months) are representative, it seems like we’d be seeing some standout long-term cases highlighted, especially as marketing material, given how impactful those kinds of gains would be.
Does the absence of such visible long-term examples suggest we should approach the real-world effectiveness with some skepticism? My family doctor pointed out several limitations in the original study, such as the small sample size, reliance on self-reported measurements, and its appearance in a lower-impact journal. He advised me not to treat the findings as conclusive proof.
I’m bringing this up not as criticism, but as a starting point for an honest discussion about how to view the treatment and its supporting evidence. Much of the marketing seems anchored in the P-Long study, yet issues like inconsistent measurement methods (for example, bone-pressed length or temporary swelling from pumping) could influence the reliability of the results.
That said, I’m genuinely empathetic toward Dr. Brandeis and understand the challenges involved in publishing one’s own research. His contributions to this space are worth recognizing, even if there are areas that invite scrutiny. What stands out to me is the lack of clear “outlier” cases backed by indisputable photographic evidence. In the study, the top gains after six months were around 1.44 inches in length and 0.75 inches in
Girth, volumetrically significant enough that strong before-and-after photos would be very compelling, and would be in my opinion much more effective than any webinar when it comes to marketing the treatment.
Any thoughts on that?